Public Health | April 25, 2026
Indian firm hosts global homoeopathy summit at UK Parliament amid rising global engagement
The summit brought together over 150 doctors, researchers, and practitioners worldwide
The summit brought together over 150 doctors, researchers, and practitioners worldwide
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
Subscribe To Our Newsletter & Stay Updated
